The purpose of the eliminating tuberculosis in central asia (ETICA) is to reduce the burden of TB in central asia by building local and regional capacity for improving the detection and treatment of…

Ended Definitive Contract Awarded Last action

Contract number
72011519C00002
Awardee
Awarding agency
Obligated
$31,352,581

Award facts

Opportunity
Contract value 100% obligated
$31,352,581.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Central Asian Republics Regional Program Overseas Missions, US Agency for International Development
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Kazakhstan

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00009 $0
Funding Only Action P00008 $3,238,684
Funding Only Action P00007 $915,000
Other Administrative Action P00006 $6,900,000
Funding Only Action P00005 $100,000
Funding Only Action P00004 $500,000
Funding Only Action P00003 $7,550,000
Funding Only Action P00002 $200,000
Funding Only Action P00001 $6,670,000
Original award $5,278,897

About this award

This is a $31,352,581.00 definitive cost-plus-fixed-fee contract awarded by the U.S. Agency for International Development (USAID) to ABT Associates Inc. to implement the Eliminating Tuberculosis in Central Asia (ETICA) project. The purpose of ETICA is to reduce the burden of drug-resistant tuberculosis in Central Asia by building local and regional capacity to improve detection and treatment.

ABT Associates is a global consulting and research firm with significant experience as a prime contractor delivering specialized expertise to support government programs through contracts and grants. The contract has no set-aside designation. ABT Associates is using several subcontractors to provide technical assistance, including Path, a global non-profit organization, as well as local organizations in Kazakhstan and Tajikistan. This contract supports USAID's Central Asian Republics tuberculosis control efforts as part of its larger portfolio of international health and development programs.

Description

The purpose of the eliminating tuberculosis in central asia (ETICA) is to reduce the burden of TB in central asia by building local and regional capacity for improving the detection and treatment of drug-resistant tuberculosis (DR-TB).

Quick answers

Who was awarded contract 72011519C00002?

72011519C00002 was awarded to ABT Global LLC by US Mission in Central Asia, Kazakhstan (Overseas Missions) on September 8, 2019.

How much is contract 72011519C00002 worth?

The government has obligated $31,352,581 on 72011519C00002.

Which agency awarded contract 72011519C00002?

US Mission in Central Asia, Kazakhstan (Overseas Missions) awarded 72011519C00002, with funding from Central Asian Republics Regional Program (Overseas Missions).

Was contract 72011519C00002 competed?

The extent of competition for 72011519C00002 was full and open competition. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award